GRPR and lip and oral cavity carcinoma: Notably, TM1-IR680 conjugated with gastrin-releasing peptide receptor (GRPR)-targeting peptides enabled intraoperative visualization of tumor margins and lymphatic metastases in orthotopic oral cancer murine models [61].